Orbital fat atrophy linked to prostaglandin analogue drops

PHILADELPHIA — Prostaglandin analogue drops induce orbital fat atrophy that may be undetected by the patient, according to a study presented here, but these changes may be detectable using a new classification system. “This is important because [the classification system] can distinguish the syndrome from the aging eyelid,” Michael P. Rabinowitz, MD, said at the Wills Eye Annual Conference. “Awareness of these signs is critical because the eyelids and eyes may be affected even in the absence of patient recognition.”

Full Story →